TRIM21 and nasopharyngeal carcinoma: We dichotomised the NPC patients into a high TRIM21 expression group and a low TRIM21 expression group for Kaplan–Meier analysis, which revealed that the patients with high TRIM21 expression had significantly shorter locoregional recurrence-free survival, disease-free survival, and overall survival times (Fig. 7f–h).